+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID05617716

Comparing Standard and High Dose Stereotactic Body Radiation Therapy Versus Conventional External Beam Radiation for Spine Metastatic Cancer A Multicenter Randomized Phase II Study

Led by University of Oklahoma · Updated on 2025-10-20

240

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing three types of radiation therapy for cancer that has spread to the spine, focusing on how well these treatments reduce pain and improve pain-free rates. Metastatic spine cancer is becoming more common as patients live longer, and current standard treatment with external beam radiation therapy EBRT has limited long-term pain control. This study aims to evaluate standard dose stereotactic body radiation therapy SBRT, higher dose SBRT, and conventional EBRT to determine which approach provides more durable pain relief for patients with spine metastases. Participants will be randomly assigned to one of three treatment groups standard dose SBRT receiving 24 Gray in 2 fractions, high dose SBRT receiving 19 Gray in 1 fraction, or conventional EBRT receiving 8 Gray in 1 fraction. Each participant will receive the assigned radiation therapy as part of their standard care. Questionnaires assessing pain Brief Pain Inventory, quality of life COST-FACIT, EuroQol EQ-5D will be completed at the start and at 3, 6, 9, and 12 months after treatment to monitor effects and outcomes. Throughout the study, participants will be evaluated using these questionnaires to measure pain freedom at 3 months as the primary outcome, with additional assessments at 6 and 12 months including local tumor control, vertebral compression fractures, and progression-free survival. The study includes follow-up visits between 3 to 12 months after treatment to monitor symptoms and quality of life. The overall goal is to better understand which radiation therapy approach offers the most effective and lasting pain relief for patients with metastatic spine cancer.

CONDITIONS

Brief Title

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

Research Team

L

Lead Onco Nurse

S

Shearwood McClelland III, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here